natgillin/translations-raw huggingface dataset:
Cattle: Subcutaneous or intravenous use Pigs: Intramuscular use
Govedo: Subkutana ali intravenska uporaba Prašiči: Intramuskularna uporaba
Cattle: Subcutaneous or Intravenous use Pigs: Intramuscular use
Govedo: subkutano ali intravensko dajanje Prašiči: intramuskularno dajanje
Cattle: Subcutaneous or Intravenous use Pigs: Intramuscular use
Govedo: subkutano ali intravensko dajanje Prašiči: intramuskularno dajanuje
Cattle: Subcutaneous use Pigs: Intramuscular use
Govedo: Subkutana uporaba Prašiči: Intramuskularna uporaba
Cattle: Subcutaneous use Pigs: Intramuscular use
Govedo: Subkutano Prašiči: intramuskularno
Cattle: subcutaneous use, intravenous use.
Govedo: subkutana uporaba, intravenska uporaba.
Cattle: The safety and efficacy of the vaccine has not been established in pregnant cattle.
Govedo: Varnosti in učinkovitosti cepiva med brejostjo niso ugotavljali.
Catumaxomab (N=170) Control (N=88)
Katumaksomab (N = 170) Kontrolna skupina (N = 88)
Catumaxomab also attaches to a third substance called the Fc-gamma receptor, which also helps the body’s immune system to target the cancer cells.
Katumaksomab se prav tako veže na tretjo snov, imenovano receptor Fc-gama, ki prav tako pomaga imunskemu sistemu telesa pri napadanju rakavih celic.
Caucasian
217)
Caucasian 34 %
Kavkazijska 34
cause hypoglycaemia.
povzroči hipoglikemijo.
caused by scleroderma (also called systemic sclerosis, a disease where there is abnormal growth of the connective tissue that supports the skin and other organs); caused by congenital (inborn) heart defects with shunts (abnormal passageways) causing abnormal flow of blood through the heart and lungs.
posledica skleroderme (imenovane tudi sistemska skleroza, bolezen nenormalne rasti vezivnega tkiva, ki podpira kožo in druge organe), posledica kongenitalne (prirojene) napake srca s šanti (nenormalni prehodi), ki povzroča nenormalen pretok krvi skozi srce in pljuča.
caused by scleroderma (also called systemic sclerosis, a disease where there is abnormal growth of the connective tissue that supports the skin and other organs); caused by congenital (inborn) heart defects with shunts (abnormal passageways) causing abnormal flow of blood through the heart and lungs.
posledica skleroderme (imenovane tudi sistemska skleroza, tj. bolezen, za katero je značilna nenormalna rast vezivnega tkiva, ki podpira kožo in druge organe); posledica kongenitalne (prirojene) srčne bolezni s šanti (nenormalnimi prehodi), ki povzroča nenormalen pretok krvi skozi srce in pljuča.
caused by scleroderma (also called systemic sclerosis, a disease where there is abnormal growth of the connective tissue that supports the skin and other organs); caused by congenital (inborn) heart defects with shunts (abnormal passageways) causing abnormal flow of blood through the heart and lungs.
posledica skleroderme, (imenovane tudi sistemska skleroza, bolezni, pri kateri pride do nenormalne rasti veznega tkiva, ki podpira kožo in druge organe); posledica kongenitalne (prirojene) srčne napake s šanti (nenormalnimi prehodi), kar povzroča nenormalen pretok krvi skozi srce in pljuča.
Causes of osteoporosis other than oestrogen deficiency and ageing should be considered.
Poleg pomanjkanja estrogena in staranja je treba upoštevati tudi druge vzroke za osteoporozo.
Causes of transient neutropenia such as viral infections should be excluded.
Izključiti je treba vzroke prehodne nevtropenije, npr. virusne okužbe.
Causes of transient neutropenia such as viral infections should be excluded.
Potrebno je izključiti vzroke prehodne nevtropenije, kot so npr. virusne okužbe.
Causing excessive foaming during reconstitution or shaking the reconstituted solution may result in problems with the amount of Herceptin that can be withdrawn from the vial.
Povzročitev pretiranega penjenja med rekonstitucijo ali tresenje že pripravljene raztopine lahko povzroči težave s količino zdravila Herceptin, ki ga odvzamemo iz viale.
Caution - do not lift the pen off your injection site until the “clicking” sound stops and you see green ticks in the injection status window.
Pozor – ne dvignite injekcijskega peresnika z mesta injiciranja, dokler se »klikanje« ne ustavi in v oknu za stanje injiciranja ne zagledate zelenih kljukic.
Caution - do not recap the pen.
Pozor – pokrovčka ne natikajte nazaj na napolnjen injekcijski peresnik.
Caution - do not recap the Zinbryta pre- filled syringe.
Pozor – na zdravilo Zinbryta napolnjena injekcijska brizga več ne nameščajte pokrovčka.
Caution - do not recap the Zinbryta pre-filled syringe.
Pozor – na zdravilo Zinbryta napolnjena injekcijska brizga več ne nameščajte pokrovčka.
Caution - do not remove the cap until you are ready to inject.
Pozor – ne odstranite pokrovčka, dokler niste pripravljeni na injiciranje.
Caution - do not touch or push down on the needle cover, you could get a needle injury.
Pozor – varovala igle se ne dotikajte in ga ne potiskajte navzdol, da se ne poškodujete.
caution and a lower dose of
zmanjšanje odmerka trazodona.
CAUTION HIGH STRENGTH
POZOR: VELIKA JAKOST
Caution in use in the elderly in light of age related risks (in particular bladder cancer, fractures and heart failure)
Opozorilo o uporabi pri starejših glede na s starostjo povezana tveganja (zlasti za rak mehurja, zlome in srčno popuščanje).
Caution in use in the elderly in light of age related risks (in particular bladder cancer, fractures and heart failure).
Opozorilo o uporabi pri starejših glede na s starostjo povezana tveganja (zlasti za rak sečnega mehurja, zlome in srčno popuščanje).
Caution in use in the elderly in light of age related risks (in particular bladder cancer, fractures and heart failure).
Opozorilo o uporabi pri starejših glede na tveganja povezana s starostjo (zlasti za rak sečnega mehurja, zlome in srčno popuščanje).
Caution in use in the elderly in light of age related risks (in particular bladder cancer, fractures and heart failure).
previdnost pri uporabi zdravila pri starejših bolnikih glede tveganj, ki so povezana s starostjo (zlasti rak mehurja, zlomi in srčno popuščanje)
Caution in use in the elderly in light of age related risks (in particular bladder cancer, fractures and heart failure).
Previdnosti pri uporabi pri starejših bolnikih v luči tveganj, povezanih s starostjo (zlasti raka sečnega mehurja, zlomov in srčnega popuščanja).
Caution is
Potrebna je
Caution is
Previdnost je
Caution is advisable if ARICLAIM is used concomitantly with serotonergic agents like SSRIs, SNRIs, tricyclic antidepressants like clomipramine or amitriptyline, MAOIs like moclobemide or linezolid, St John’s wort (Hypericum perforatum) or triptans, tramadol, pethidine and tryptophan (see section 4.4).
Če zdravilo ARICLAIM uporabljamo sočasno s serotonergičnimi zdravili, kot so SSRI, SNRI, s tricikličnimi antidepresivi, denimo, klomipraminom ali amitriptilinom, z MAOI, denimo moklobemidom ali linezolidom, s šentjanževko (Hypericum perforatum), triptani, tramadolom, petidinom in triptofanom, priporočamo previdnost (glejte poglavje 4.4).
Caution is advisable if ARICLAIM is used concomitantly with serotonergic agents like SSRIs, SNRIs, tricyclic antidepressants like clomipramine or amitriptyline, MAOIs like moclobemide or linezolid, St John’s wort (Hypericum perforatum), or triptans, tramadol, pethidine and tryptophan (see section 4.4).
Če zdravilo ARICLAIM uporabljamo sočasno s serotonergičnimi zdravili, kot so SSRI, SNRI, s tricikličnimi antidepresivi, denimo, klomipraminom ali amitriptilinom, z MAOI, denimo moklobemidom ali linezolidom, s šentjanževko (Hypericum perforatum), triptani, tramadolom, petidinom in triptofanom, priporočamo previdnost (glejte poglavje 4.4).
Caution is advisable if Cymbalta is used concomitantly with serotonergic agents like SSRIs, SNRIs, tricyclic antidepressants like clomipramine or amitriptyline, MAOIs like moclobemide or linezolid, St John’s wort (Hypericum perforatum) or triptans, tramadol, pethidine and tryptophan (see section 4.4).
Če zdravilo Cymbalta uporabljamo sočasno s serotonergičnimi zdravili, kot so SSRI, SNRI, s tricikličnimi antidepresivi, denimo, klomipraminom ali amitriptilinom, z MAOI, denimo moklobemidom ali linezolidom, s šentjanževko (Hypericum perforatum), triptani, tramadolom, petidinom in triptofanom, priporočamo previdnost (glejte poglavje 4.4).
Caution is advisable if DULOXETINE BOEHRINGER INGELHEIM is used concomitantly with serotonergic antidepressants like SSRIs, tricyclics like clomipramine or amitriptyline, St John’s wort (Hypericum perforatum), venlafaxine or triptans, tramadol, pethidine and tryptophan.
Če zdravilo DULOKSETIN BOEHRINGER INGELHEIM uporabljamo sočasno s serotonergičnimi antidepresivi, kot so SSRI, tricikličnimi antidepresivi, denimo, klomipraminom ali amitriptilinom, šentjanževko (Hypericum perforatum), venlafaksinom ali triptani, tramadolom, petidinom in triptofanom, priporočamo previdnost.
Caution is advisable if duloxetine is used concomitantly with serotonergic agents like SSRIs, SNRIs, tricyclic antidepressants like clomipramine or amitriptyline, MAOIs like moclobemide or linezolid, St. John’s wort (Hypericum perforatum) or triptans, tramadol, pethidine and tryptophan (see section 4.4).
Če duloksetin uporabljamo sočasno s serotonergičnimi zdravili, kot so SSRI, SNRI, s tricikličnimi antidepresivi, denimo, klomipraminom ali amitriptilinom, z MAOI, denimo moklobemidom ali linezolidom, s šentjanževko (Hypericum perforatum), triptani, tramadolom, petidinom in triptofanom, priporočamo previdnost (glejte poglavje 4.4).
Caution is advisable if Duloxetine Lilly is used concomitantly with serotonergic agents like SSRIs, SNRIs, tricyclic antidepressants like clomipramine or amitriptyline, MAOIs like moclobemide or linezolid, St John’s wort (Hypericum perforatum) or triptans, tramadol, pethidine and tryptophan (see section 4.4).
Če zdravilo Duloxetine Lilly uporabljamo sočasno s serotonergičnimi zdravili, kot so SSRI, SNRI, s tricikličnimi antidepresivi, denimo, klomipraminom ali amitriptilinom, z MAOI, denimo moklobemidom ali linezolidom, s šentjanževko (Hypericum perforatum) ali triptanima, tramadolom, petidinom in triptofanom, priporočamo previdnost (glejte poglavje 4.4).
Caution is advisable if Duloxetine Lilly is used concomitantly with serotonergic agents like SSRIs, SNRIs, tricyclic antidepressants like clomipramine or amitriptyline, MAOIs like moclobemide or linezolid, St John’s wort (Hypericum perforatum) or triptans, tramadol, pethidine and tryptophan (see section 4.4).
Če zdravilo Duloxetine Lilly uporabljamo sočasno s serotonergičnimi zdravili, kot so SSRI, SNRI, s tricikličnimi antidepresivi, denimo, klomipraminom ali amitriptilinom, z MAOI, denimo moklobemidom ali linezolidom, s šentjanževko (Hypericum perforatum), triptani, tramadolom, petidinom in triptofanom, priporočamo previdnost (glejte poglavje 4.4).
Caution is advisable if Duloxetine Mylan is used concomitantly with serotonergic agents like SSRIs, SNRIs, tricyclic antidepressants like clomipramine or amitriptyline, MAOIs like moclobemide or linezolid, St John’s wort (Hypericum perforatum) or triptans, tramadol, pethidine and tryptophan (see section 4.4).
Če zdravilo Duloksetin Mylan uporabljamo sočasno s serotonergičnimi zdravili, kot so SSRI, SNRI, s tricikličnimi antidepresivi, denimo klomipraminom ali amitriptilinom, z MAOI, denimo moklobemidom ali linezolidom, s šentjanževko (Hypericum perforatum), triptani, tramadolom, petidinom in triptofanom, priporočamo previdnost (glejte poglavje 4.4).
Caution is advisable if Xeristar is used concomitantly with serotonergic agents like SSRIs, SNRIs, tricyclic antidepressants like clomipramine or amitriptyline, MAOIs like moclobemide or linezolid, St John’s wort (Hypericum perforatum) or triptans, tramadol, pethidine and tryptophan (see section 4.4).
Če zdravilo Xeristar uporabljamo sočasno s serotonergičnimi zdravili, kot so SSRI, SNRI, s tricikličnimi antidepresivi, denimo, klomipraminom ali amitriptilinom, z MAOI, denimo moklobemidom ali linezolidom, s šentjanževko (Hypericum perforatum), triptani, tramadolom, petidinom in triptofanom, priporočamo previdnost (glejte poglavje 4.4).
Caution is advisable if YENTREVE is used concomitantly with serotonergic agents like SSRIs, SNRIs, tricyclic antidepressants like clomipramine or amitriptyline, MAOIs like moclobemide or linezolid, St John’s wort (Hypericum perforatum) or triptans, tramadol pethidine and tryptophan (see section 4.4).
Če zdravilo YENTREVE uporabljamo sočasno s serotonergičnimi zdravili, kot so SSRI, SNRI, s tricikličnimi antidepresivi, denimo, klomipraminom ali amitriptilinom, z MAOI, denimo moklobemidom ali linezolidom, s šentjanževko (Hypericum perforatum), triptani, tramadolom, petidinom in triptofanom, priporočamo previdnost (glejte poglavje 4.4).
Caution is advisable if YENTREVE is used concomitantly with serotonergic agents like SSRIs, SNRIs, tricyclic antidepressants like clomipramine or amitriptyline, MOAIs like moclobemide or linezolid, St John’s wort (Hypericum perforatum) or triptans, tramadol, pethidine and tryptophan (see section 4.4).
Če zdravilo YENTREVE uporabljamo sočasno s serotonergičnimi zdravili, kot so SSRI, SNRI, s tricikličnimi antidepresivi, denimo, klomipraminom ali amitriptilinom, z MAOI, denimo moklobemidom ali linezolidom, s šentjanževko (Hypericum perforatum), triptani, tramadolom, petidinom in triptofanom, priporočamo previdnost (glejte poglavje 4.4).
Caution is advised and combination with these medicinal products should if possible be avoided.
Potrebna je previdnost, kombinaciji s temi zdravili pa se je treba izogibati, če je to mogoče.
Caution is advised and monitoring for adrenocortical insufficiency should occur if patients are withdrawn from prednisone or prednisolone.
Pri ukinitvi prednizona oziroma prednizolona je potrebna previdnost, bolnika pa je treba opazovati glede razvoja adrenokortikalne insuficience.
Caution is advised due to the possibility of an additive or potentiating effect with CNS depressants (e.g. alcohol, barbiturates, opiates, sedatives, or anaesthetics).
Zaradi nevarnosti za aditivno delovanje ali povečanje učinka je potrebna previdnost z depresorji centralnega živčnega sistema (npr. alkoholom, barbiturati, opiati, sedativi ali anestetiki).
Caution is advised during co- administration of posaconazole with CYP3A4 substrates administered intravenously and the dose of the CYP3A4 substrate may need to be reduced.
Med sočasno uporabo posakonazola in intravensko danih substratov CYP3A4 je potrebna previdnost in po potrebi zmanjšanje odmerka substrata CYP3A4.
Caution is advised during co- administration of posaconazole with CYP3A4 substrates administered intravenously and the dose of the CYP3A4 substrate may need to be reduced.
Med sočasno uporabo posakonazola in intravensko danih substratov CYP3A4 svetujemo previdnost in lahko bo tudi potrebno zmanjšanje odmerka substrata CYP3A4.
Caution is advised if ARICLAIM is co-administered with medicinal products that are predominantly metabolised by CYP2D6 (risperidone, tricyclic antidepressants [TCAs] such as nortriptyline, amitriptyline, and imipramine) particularly if they have a narrow therapeutic index (such as flecainide, propafenone and metoprolol).
Če zdravilo ARICLAIM dajemo sočasno z zdravili, ki jih presnavlja predvsem CYP2D6 (risperidon, triciklični antidepresivi [tricyclic antidepressants, TCAs], kot so nortriptilin, amitriptilin in imipramin) in zlasti če imajo ozek terapevtski indeks (kot na primer s flekainidom, propafenonom in metoprololom), svetujemo previdnost.
Caution is advised if co-administering Viekirax with medicinal products that are both moderate inhibitors of CYP3A4 and inhibitors of multiple transporters (P-gp, BCRP and/or OATP1B1/ OATP1B3).
Previdnost je potrebna v primeru sočasne uporabe zdravila Viekirax z zdravili, ki so zmerni zaviralci CYP3A4 in zaviralci več prenašalcev (P-gp, BCRP in/ali OATP1B1/OATP1B3).
Caution is advised if Cymbalta is co-administered with medicinal products that are predominantly metabolised by CYP2D6 (risperidone, tricyclic antidepressants [TCAs] such as nortriptyline, amitriptyline, and imipramine) particularly if they have a narrow therapeutic index (such as flecainide, propafenone and metoprolol).
Če zdravilo Cymbalta dajemo sočasno z zdravili, ki jih presnavlja predvsem CYP2D6 (risperidon, triciklični antidepresivi [tricyclic antidepressants, TCAs], kot so nortriptilin, amitriptilin in imipramin) in zlasti če imajo ozek terapevtski indeks (kot na primer s flekainidom, propafenonom in metoprololom), svetujemo previdnost.
Caution is advised if Duloxetine Lilly is co-administered with medicinal products that are predominantly metabolised by CYP2D6 (risperidone, tricyclic antidepressants [TCAs] such as nortriptyline, amitriptyline, and imipramine) particularly if they have a narrow therapeutic index (such as flecainide, propafenone and metoprolol).
Če zdravilo Duloxetine Lilly dajemo sočasno z zdravili, ki jih presnavlja predvsem CYP2D6 (risperidon, triciklični antidepresivi [tricyclic antidepressants, TCAs], kot so nortriptilin, amitriptilin in imipramin) in zlasti če imajo ozek terapevtski indeks (kot na primer s flekainidom, propafenonom in metoprololom), svetujemo previdnost.
Caution is advised if mirabegron is co-administered with medicinal products with a narrow therapeutic index and significantly metabolised by CYP2D6, such as thioridazine, Type 1C antiarrhythmics (e.g., flecainide, propafenone) and tricyclic antidepressants (e.g., imipramine, desipramine).
Previdnost je potrebna, če je mirabegron uporabljen sočasno z zdravili, ki imajo ozek terapevtski indeks in se v pomembni meri presnavljajo s CYP2D6, npr. s tioridazinom, antiaritmiki skupine 1C (npr. s flekainidom, propafenonom) ali tricikličnimi antidepresivi (npr. z imipraminom, dezipraminom).
Caution is advised if paliperidone is combined with other medicinal products known to lower the seizure threshold (i.e., phenothiazines or butyrophenones, tricyclics or SSRIs, tramadol, mefloquine, etc.).
Če se paliperidon uporablja sočasno z zdravili, ki znižajo prag za epileptične napade (npr. fenotiazini ali butirofenoni, triciklični antidepresivi ali selektivni zaviralci ponovnega privzema serotonina (SSRI), tramadol meflokin itd.), je potrebna previdnost.
Caution is advised if the recommended dose of fosamprenavir with ritonavir detailed below are exceeded (see section 4.4).
V primeru prekoračitve spodaj navedenih priporočenih odmerkov zdravila Telzir v kombinaciji z ritonavirjem je potrebna previdnost (glejte poglavje 4.4).
Caution is advised if Tyverb is prescribed to patients with severe renal impairment (see sections 4.2 and 5.2).
Pri predpisovanju zdravila Tyverb bolnikom s hudo okvaro ledvic svetujemo previdnost (glejte poglavji 4.2 in 5.2).
Caution is advised if Xeristar is co-administered with medicinal products that are predominantly metabolised by CYP2D6 (risperidone, tricyclic antidepressants [TCAs] such as nortriptyline, amitriptyline, and imipramine) particularly if they have a narrow therapeutic index (such as flecainide, propafenone and metoprolol).
Če zdravilo Xeristar dajemo sočasno z zdravili, ki jih presnavlja predvsem CYP2D6 (risperidon, triciklični antidepresivi [tricyclic antidepressants, TCAs], kot so nortriptilin, amitriptilin in imipramin) in zlasti če imajo ozek terapevtski indeks (kot na primer s flekainidom, propafenonom in metoprololom), svetujemo previdnost.
Caution is advised if YENTREVE is co-administered with medicinal products that are predominantly metabolised by CYP2D6 (risperidone, tricyclic antidepressants [TCAs] such as nortriptyline, amitriptyline, and imipramine) particularly if they have a narrow therapeutic index (such as flecainide, propafenone and metoprolol).
Če duloksetin dajemo sočasno z zdravili, ki jih presnavlja predvsem CYP2D6 (risperidon, triciklični antidepresivi [tricyclic antidepressants, TCAs], kot so nortriptilin, amitriptilin in imipramin) in zlasti če imajo ozek terapevtski indeks (kot na primer s flekainidom, propafenonom in metoprololom), svetujemo previdnost.
Caution is advised in case of combination with CYP3A4 substrates having a narrow therapeutic margin i.e. immunosuppressive agents (cyclosporine, tacrolimus, sirolimus) as well as CYP3A4- metabolised cytotoxics, i.e. cyclophosphamide, etoposide, finasteride, ifosfamide, tamoxifen, vinca- alcaloids.
Previdnost je potrebna pri kombinacijah substratov za CYP3A4 z majhno terapevtsko širino, t.j. pri imunosupresivnih sredstvih (ciklosporin, takrolimus, sirolimus), pa tudi pri citotoksičnih sredstvih, ki jih presnavlja CYP3A4, kot so ciklofosfamid, etopozid, finasterid, ifosfamid, tamoksifen, alkaloidi vinca.
Caution is advised in patients receiving other medicinal products that may affect renal function or are excreted renally (e.g. cyclosporin and tacrolimus, intravenous aminoglycosides, amphotericin B, foscarnet, pentamidine, vancomycin, or medicinal products which are secreted by the same renal transporter, human Organic Anion Transporter 1 (hOAT1), such as cidofovir).
Pri bolnikih, ki prejemajo druga zdravila, ki lahko vplivajo na ledvično funkcijo ali se izločajo preko ledvic (npr. ciklosporin in takrolimus, intravenski aminoglikozidi, amfotericin B, foskarnet, pentamidin, vankomicin in zdravila, ki se izločajo preko istega ledvičnega prenašalca (hOAT1, human Organic Anion Transporter 1) kot je cidofovir), je potrebna previdnost.
Caution is advised in patients taking anticoagulants and/or medicinal products known to affect platelet function [e.g., atypical antipsychotics and phenothiazines, most tricyclic antidepressants, non-steroidal anti-inflammatory drugs (NSAIDs), acetylsalicylic acid (ASA)] (see section 4.5) and in patients with known bleeding tendencies/disorders.
Pri bolnikih, ki jemljejo zdravila proti strjevanju krvi in/ali druga zdravila, za katere je znano, da vplivajo na delovanje trombocitov [npr. atipični antipsihotiki in fenotiazini, večina tricikličnih antidepresivov, nesteroidna protivnetna zdravila (NSAID), acetilsalicilna kislina (ASA)] (glejte poglavje 4.5), ter pri bolnikih z znano nagnjenostjo h krvavitvam/motnjami krvavitev je potrebna previdnost.
Caution is advised in the treatment of patients most at risk of developing a gastrointestinal complication with NSAIDs; the elderly, patients using any other NSAID or acetylsalicylic acid concomitantly, glucocorticoids, selective serotonin reuptake inhibitors or patients with a prior history of gastrointestinal disease, such as ulceration and GI bleeding.
Med zdravljenjem je potrebna previdnost pri bolnikih, ki jih ob uporabi nesteroidnih protivnetnih zdravil najbolj ogrožajo zapleti na prebavilih, pri starejših, pri bolnikih, ki sočasno jemljejo kakšno drugo nesteroidno protivnetno zdravilo ali acetilsalicilno kislino, glukokortikoide, selektivne zaviralce ponovnega privzema serotonina in pri bolnikih z anamnezo bolezni prebavil, npr. razjede ali krvavitve v prebavilih.
Caution is advised in the treatment of patients most at risk of developing a gastrointestinal complication with NSAIDs; the elderly, patients using any other NSAID or acetylsalicylic acid concomitantly, glucocorticoids, selective serotonin reuptake inhibitors, or patients with a prior history of gastrointestinal disease, such as ulceration and GI bleeding.
Med zdravljenjem je potrebna previdnost pri bolnikih, ki jih ob uporabi nesteroidnih protivnetnih zdravil najbolj ogrožajo zapleti na prebavilih, pri starejših, pri bolnikih, ki sočasno jemljejo kakšno drugo nesteroidno protivnetno zdravilo ali acetilsalicilno kislino, glukokortikoide, selektivne zaviralce ponovnega privzema serotonina in pri bolnikih z anamnezo bolezni prebavil, npr. razjede ali krvavitve v prebavilih.
Caution is advised when administering Cayston to patients if they have a history of beta-lactam allergy.
Pri uporabi zdravila Cayston pri bolnikih z anamnezo alergije na betalaktam je potrebna previdnost.
Caution is advised when administering with medicinal products activated by or metabolised by CYP2D6, particularly with medicinal products that have a narrow therapeutic index.
Pri sočasni uporabi z zdravili, ki jih aktivira ali presnavlja CYP2D6, zlasti tistih z majhno terapevtsko širino je potrebna previdnost.